Shuttle Pharmaceuticals Holdings (SHPH) Operating Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Operating Expenses history runs 6 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 24.89% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $11.9 million (up 28.41% YoY), while the FY2025 annual figure was $11.9 million, up 54.84% from the prior year.
• Operating Expenses was $2.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $3.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $3.9 million in Q2 2025 to a low of $353626.0 in Q2 2022.
• Historically, Operating Expenses has averaged $1.8 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses tumbled 46.35% in 2022, then soared 314.46% in 2023.
• A 5-year view of Operating Expenses shows it stood at $530336.0 in 2022, then jumped by 141.89% to $1.3 million in 2023, then soared by 38.53% to $1.8 million in 2024, then surged by 96.95% to $3.5 million in 2025, then slumped by 36.66% to $2.2 million in 2026.
• The last three Operating Expenses figures came in at $2.2 million (Q1 2026), $3.5 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.